This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Targeted Anticancer Drugs and Immunosuppressants, Subject name: Pharmacology
Which of the following is a new drug recently approved for treatment of neovascular age related macular degeneration? 
Select and explain. 
A. Brolucizumab, B. Istradefylline, C. Lefamulin, D. Upadacitinib
A: Brolucizumab
Answer: A: Brolucizumab 
Explanation: *Brolucizumab is a monoclonal antibody against VEGF. *It is recently approved for wet (neovascular) age related macular degeneration.* Istradefylline is adenosine A2 receptor antagonist. It is approved for off episodes in Parkinsonism* Lefamulin is a new antimicrobial that acts by inhibiting protein synthesis. It is approved for community acquired bacterial pneumonia.